🇺🇸 FDA
Patent

US 12390463

Dosage forms and regimens for amino acid compounds

granted A61KA61K31/4375A61K31/4439

Quick answer

US patent 12390463 (Dosage forms and regimens for amino acid compounds) held by Pliant Therapeutics, Inc. expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pliant Therapeutics, Inc.
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/4375, A61K31/4439, A61K31/496, A61K31/498